These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6228780)

  • 1. The human C3b receptor.
    Cook J; Kazatchkine M
    Nouv Rev Fr Hematol (1978); 1983; 25(5):297-301. PubMed ID: 6228780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human C3b receptor (CR1).
    Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
    Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the human C3b receptor.
    Fearon DT
    Fed Proc; 1984 Jul; 43(10):2553-7. PubMed ID: 6234186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME; Kinoshita T; Nussenzweig V
    J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    Fearon DT
    J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human C3b receptor: function and role in human diseases.
    Tausk F; Gigli I
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):141S-145S. PubMed ID: 2141047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement receptor is an inhibitor of the complement cascade.
    Iida K; Nussenzweig V
    J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Miyamoto T
    J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of C3b in complex with CRIg gives insights into regulation of complement activation.
    Wiesmann C; Katschke KJ; Yin J; Helmy KY; Steffek M; Fairbrother WJ; McCallum SA; Embuscado L; DeForge L; Hass PE; van Lookeren Campagne M
    Nature; 2006 Nov; 444(7116):217-20. PubMed ID: 17051150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human C3b receptor.
    Fearon DT
    Springer Semin Immunopathol; 1983; 6(2-3):159-72. PubMed ID: 6227098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of C3b receptor-like activity and of decay-accelerating factor-like activity on rabbit erythrocytes.
    Horstmann RD; Müller-Eberhard HJ
    Eur J Immunol; 1986 Sep; 16(9):1069-73. PubMed ID: 2428623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.